APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antifungal Drugs for Skin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antifungal Drugs for Skin Market Outlook and Growth Opportunities 2026

27 December 2025218 pages

Choose your research edition.

Industry ResearchAntifungal Drugs for Skin Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Antifungal Drugs for Skin Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Antifungal Drugs for Skin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antifungal Drugs for Skin Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Antifungal Drugs for Skin Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Antifungal Drugs for Skin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antifungal Drugs for Skin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antifungal Drugs for Skin market include Aden Healthcare, AdvaCare Pharma, Amar Healthcare, AS lifesciences, Dr. Reddy's Laboratories, Pfizer, Shree Ganesh Remedies, Solisom Healthcare and Wellona Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antifungal Drugs for Skin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antifungal Drugs for Skin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antifungal Drugs for Skin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antifungal Drugs for Skin market size, projected growth trends, production technologies, key applications, and end-use industries.

Antifungal Drugs for Skin Segment by Company

Aden Healthcare

AdvaCare Pharma

Amar Healthcare

AS lifesciences

Dr. Reddy's Laboratories

Pfizer

Shree Ganesh Remedies

Solisom Healthcare

Wellona Pharma

Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.

Harbin Labton Pharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Bioengineering Co., Ltd.

Hubei Hengan Fulin Pharmaceutical Co., Ltd.

Jiangsu Chenpai Pharmaceutical Group Co., Ltd.

Livzon Group Livzon Pharmaceutical Factory

Lunan Beite Pharmaceutical Co., Ltd.

Nanjing Chengong Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.

Shandong Chenxin Fodu Pharmaceutical Co., Ltd.

Shandong Fangming Pharmaceutical Group Co., Ltd.

Shanghai Baolong Pharmaceutical Co., Ltd.

Teyi Pharmaceutical Group Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Yunnan Longrun Pharmaceutical Co., Ltd.

Zhejiang East Asia Pharmaceutical Co., Ltd.

Antifungal Drugs for Skin Segment by Type

Amorolfine

Butenafine

Ciprofloxacin

Clotrimazole

Miconazole

Terbinafine

Ketoconazole

Econazole

Other

Antifungal Drugs for Skin Segment by Application

Hospital

Clinic

Other

Antifungal Drugs for Skin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antifungal Drugs for Skin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Antifungal Drugs for Skin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antifungal Drugs for Skin significant trends, drivers, influence factors in global and regions.

6. To analyze Antifungal Drugs for Skin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antifungal Drugs for Skin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antifungal Drugs for Skin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antifungal Drugs for Skin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antifungal Drugs for Skin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antifungal Drugs for Skin industry.

Chapter 3: Detailed analysis of Antifungal Drugs for Skin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Antifungal Drugs for Skin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Antifungal Drugs for Skin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antifungal Drugs for Skin Industry Trends Table 2. Antifungal Drugs for Skin Industry Drivers Table 3. Antifungal Drugs for Skin Industry Opportunities and Challenges Table 4. Antifungal Drugs for Skin Industry Restraints Table 5. Global Antifungal Drugs for Skin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antifungal Drugs for Skin Revenue Share by Company (2021-2026) Table 7. Global Antifungal Drugs for Skin Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Antifungal Drugs for Skin Sales Volume Share by Company (2021-2026) Table 9. Global Antifungal Drugs for Skin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Antifungal Drugs for Skin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Antifungal Drugs for Skin Key Company Manufacturing Base & Headquarters Table 12. Global Antifungal Drugs for Skin Company, Product Type & Application Table 13. Global Antifungal Drugs for Skin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Antifungal Drugs for Skin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Amorolfine Table 18. Significant Companies of Butenafine Table 19. Significant Companies of Ciprofloxacin Table 20. Significant Companies of Clotrimazole Table 21. Significant Companies of Miconazole Table 22. Significant Companies of Terbinafine Table 23. Significant Companies of Ketoconazole Table 24. Significant Companies of Econazole Table 25. Significant Companies of Other Table 26. Global Antifungal Drugs for Skin Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Antifungal Drugs for Skin Sales Volume by Type (2021-2026) & (K Units) Table 28. Global Antifungal Drugs for Skin Sales Volume by Type (2027-2032) & (K Units) Table 29. Global Antifungal Drugs for Skin Sales Volume Share by Type (2021-2026) Table 30. Global Antifungal Drugs for Skin Sales Volume Share by Type (2027-2032) Table 31. Global Antifungal Drugs for Skin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Antifungal Drugs for Skin Sales Value by Type (2021-2026) & (US$ Million) Table 33. Global Antifungal Drugs for Skin Sales Value by Type (2027-2032) & (US$ Million) Table 34. Global Antifungal Drugs for Skin Sales Value Share by Type (2021-2026) Table 35. Global Antifungal Drugs for Skin Sales Value Share by Type (2027-2032) Table 36. Significant Companies of Hospital Table 37. Significant Companies of Clinic Table 38. Significant Companies of Other Table 39. Global Antifungal Drugs for Skin Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Antifungal Drugs for Skin Sales Volume by Application (2021-2026) & (K Units) Table 41. Global Antifungal Drugs for Skin Sales Volume by Application (2027-2032) & (K Units) Table 42. Global Antifungal Drugs for Skin Sales Volume Share by Application (2021-2026) Table 43. Global Antifungal Drugs for Skin Sales Volume Share by Application (2027-2032) Table 44. Global Antifungal Drugs for Skin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Antifungal Drugs for Skin Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Antifungal Drugs for Skin Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Antifungal Drugs for Skin Sales Value Share by Application (2021-2026) Table 48. Global Antifungal Drugs for Skin Sales Value Share by Application (2027-2032) Table 49. Global Antifungal Drugs for Skin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 50. Global Antifungal Drugs for Skin Sales by Region (2021-2026) & (K Units) Table 51. Global Antifungal Drugs for Skin Sales Market Share by Region (2021-2026) Table 52. Global Antifungal Drugs for Skin Sales by Region (2027-2032) & (K Units) Table 53. Global Antifungal Drugs for Skin Sales Market Share by Region (2027-2032) Table 54. Global Antifungal Drugs for Skin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Antifungal Drugs for Skin Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Antifungal Drugs for Skin Sales Value Share by Region (2021-2026) Table 57. Global Antifungal Drugs for Skin Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Antifungal Drugs for Skin Sales Value Share by Region (2027-2032) Table 59. Global Antifungal Drugs for Skin Market Average Price (US$/Unit) by Region (2021-2026) Table 60. Global Antifungal Drugs for Skin Market Average Price (US$/Unit) by Region (2027-2032) Table 61. Global Antifungal Drugs for Skin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. Global Antifungal Drugs for Skin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 64. Global Antifungal Drugs for Skin Sales Market Share by Country (2021-2026) Table 65. Global Antifungal Drugs for Skin Sales by Country (2027-2032) & (K Units) Table 66. Global Antifungal Drugs for Skin Sales Market Share by Country (2027-2032) Table 67. Global Antifungal Drugs for Skin Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Antifungal Drugs for Skin Sales Value Market Share by Country (2021-2026) Table 69. Global Antifungal Drugs for Skin Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Antifungal Drugs for Skin Sales Value Market Share by Country (2027-2032) Table 71. Aden Healthcare Company Information Table 72. Aden Healthcare Business Overview Table 73. Aden Healthcare Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Aden Healthcare Antifungal Drugs for Skin Product Portfolio Table 75. Aden Healthcare Recent Development Table 76. AdvaCare Pharma Company Information Table 77. AdvaCare Pharma Business Overview Table 78. AdvaCare Pharma Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. AdvaCare Pharma Antifungal Drugs for Skin Product Portfolio Table 80. AdvaCare Pharma Recent Development Table 81. Amar Healthcare Company Information Table 82. Amar Healthcare Business Overview Table 83. Amar Healthcare Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Amar Healthcare Antifungal Drugs for Skin Product Portfolio Table 85. Amar Healthcare Recent Development Table 86. AS lifesciences Company Information Table 87. AS lifesciences Business Overview Table 88. AS lifesciences Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. AS lifesciences Antifungal Drugs for Skin Product Portfolio Table 90. AS lifesciences Recent Development Table 91. Dr. Reddy's Laboratories Company Information Table 92. Dr. Reddy's Laboratories Business Overview Table 93. Dr. Reddy's Laboratories Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Dr. Reddy's Laboratories Antifungal Drugs for Skin Product Portfolio Table 95. Dr. Reddy's Laboratories Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pfizer Antifungal Drugs for Skin Product Portfolio Table 100. Pfizer Recent Development Table 101. Shree Ganesh Remedies Company Information Table 102. Shree Ganesh Remedies Business Overview Table 103. Shree Ganesh Remedies Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shree Ganesh Remedies Antifungal Drugs for Skin Product Portfolio Table 105. Shree Ganesh Remedies Recent Development Table 106. Solisom Healthcare Company Information Table 107. Solisom Healthcare Business Overview Table 108. Solisom Healthcare Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Solisom Healthcare Antifungal Drugs for Skin Product Portfolio Table 110. Solisom Healthcare Recent Development Table 111. Wellona Pharma Company Information Table 112. Wellona Pharma Business Overview Table 113. Wellona Pharma Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Wellona Pharma Antifungal Drugs for Skin Product Portfolio Table 115. Wellona Pharma Recent Development Table 116. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Company Information Table 117. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Business Overview Table 118. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 120. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Recent Development Table 121. Harbin Labton Pharmaceutical Co., Ltd. Company Information Table 122. Harbin Labton Pharmaceutical Co., Ltd. Business Overview Table 123. Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 125. Harbin Labton Pharmaceutical Co., Ltd. Recent Development Table 126. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Company Information Table 127. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Business Overview Table 128. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 130. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Recent Development Table 131. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Company Information Table 132. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Business Overview Table 133. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 135. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Recent Development Table 136. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Company Information Table 137. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Business Overview Table 138. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 140. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Recent Development Table 141. Livzon Group Livzon Pharmaceutical Factory Company Information Table 142. Livzon Group Livzon Pharmaceutical Factory Business Overview Table 143. Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Product Portfolio Table 145. Livzon Group Livzon Pharmaceutical Factory Recent Development Table 146. Lunan Beite Pharmaceutical Co., Ltd. Company Information Table 147. Lunan Beite Pharmaceutical Co., Ltd. Business Overview Table 148. Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 150. Lunan Beite Pharmaceutical Co., Ltd. Recent Development Table 151. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information Table 152. Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview Table 153. Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 155. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Development Table 156. Qilu Pharmaceutical Co., Ltd. Company Information Table 157. Qilu Pharmaceutical Co., Ltd. Business Overview Table 158. Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 160. Qilu Pharmaceutical Co., Ltd. Recent Development Table 161. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information Table 162. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview Table 163. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 165. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Development Table 166. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information Table 167. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview Table 168. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 170. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Development Table 171. Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information Table 172. Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview Table 173. Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 175. Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Development Table 176. Shanghai Baolong Pharmaceutical Co., Ltd. Company Information Table 177. Shanghai Baolong Pharmaceutical Co., Ltd. Business Overview Table 178. Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 180. Shanghai Baolong Pharmaceutical Co., Ltd. Recent Development Table 181. Teyi Pharmaceutical Group Co., Ltd. Company Information Table 182. Teyi Pharmaceutical Group Co., Ltd. Business Overview Table 183. Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 184. Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 185. Teyi Pharmaceutical Group Co., Ltd. Recent Development Table 186. Southwest Pharmaceutical Co., Ltd. Company Information Table 187. Southwest Pharmaceutical Co., Ltd. Business Overview Table 188. Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 189. Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 190. Southwest Pharmaceutical Co., Ltd. Recent Development Table 191. Yunnan Longrun Pharmaceutical Co., Ltd. Company Information Table 192. Yunnan Longrun Pharmaceutical Co., Ltd. Business Overview Table 193. Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 194. Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 195. Yunnan Longrun Pharmaceutical Co., Ltd. Recent Development Table 196. Zhejiang East Asia Pharmaceutical Co., Ltd. Company Information Table 197. Zhejiang East Asia Pharmaceutical Co., Ltd. Business Overview Table 198. Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 199. Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 200. Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Development Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Antifungal Drugs for Skin Distributors List Table 204. Antifungal Drugs for Skin Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Antifungal Drugs for Skin Product Image Figure 2. Global Antifungal Drugs for Skin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antifungal Drugs for Skin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Antifungal Drugs for Skin Sales (2021-2032) & (K Units) Figure 5. Global Antifungal Drugs for Skin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Antifungal Drugs for Skin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Amorolfine Image Figure 10. Butenafine Image Figure 11. Ciprofloxacin Image Figure 12. Clotrimazole Image Figure 13. Miconazole Image Figure 14. Terbinafine Image Figure 15. Ketoconazole Image Figure 16. Econazole Image Figure 17. Other Image Figure 18. Global Antifungal Drugs for Skin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Antifungal Drugs for Skin Sales Volume Share 2021 VS 2025 VS 2032 Figure 20. Global Antifungal Drugs for Skin Sales Volume Share by Type (2021-2032) Figure 21. Global Antifungal Drugs for Skin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Antifungal Drugs for Skin Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Antifungal Drugs for Skin Sales Value Share by Type (2021-2032) Figure 24. Hospital Image Figure 25. Clinic Image Figure 26. Other Image Figure 27. Global Antifungal Drugs for Skin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Antifungal Drugs for Skin Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Antifungal Drugs for Skin Sales Volume Share by Application (2021-2032) Figure 30. Global Antifungal Drugs for Skin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Antifungal Drugs for Skin Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Antifungal Drugs for Skin Sales Value Share by Application (2021-2032) Figure 33. Global Antifungal Drugs for Skin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 34. Global Antifungal Drugs for Skin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Antifungal Drugs for Skin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Antifungal Drugs for Skin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Antifungal Drugs for Skin Sales Value (2021-2032) & (US$ Million) Figure 38. North America Antifungal Drugs for Skin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Antifungal Drugs for Skin Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Antifungal Drugs for Skin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Antifungal Drugs for Skin Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Antifungal Drugs for Skin Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Antifungal Drugs for Skin Sales Value (2021-2032) & (US$ Million) Figure 44. South America Antifungal Drugs for Skin Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Antifungal Drugs for Skin Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Antifungal Drugs for Skin Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Antifungal Drugs for Skin Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Antifungal Drugs for Skin Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • Amorolfine
  • Butenafine
  • Ciprofloxacin
  • Clotrimazole
  • Miconazole
  • Terbinafine
  • Ketoconazole
  • Econazole
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Aden Healthcare
  • AdvaCare Pharma
  • Amar Healthcare
  • AS lifesciences
  • Dr. Reddy's Laboratories
  • Pfizer
  • Shree Ganesh Remedies
  • Solisom Healthcare
  • Wellona Pharma
  • Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
  • Harbin Labton Pharmaceutical Co., Ltd.
  • Harbin Pharmaceutical Group Bioengineering Co., Ltd.
  • Hubei Hengan Fulin Pharmaceutical Co., Ltd.
  • Jiangsu Chenpai Pharmaceutical Group Co., Ltd.
  • Livzon Group Livzon Pharmaceutical Factory
  • Lunan Beite Pharmaceutical Co., Ltd.
  • Nanjing Chengong Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  • Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  • Shandong Fangming Pharmaceutical Group Co., Ltd.
  • Shanghai Baolong Pharmaceutical Co., Ltd.
  • Teyi Pharmaceutical Group Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Yunnan Longrun Pharmaceutical Co., Ltd.
  • Zhejiang East Asia Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antifungal Drugs for Skin Sales Value (2021-2032)
  4. 1.2.2 Global Antifungal Drugs for Skin Sales Volume (2021-2032)
  5. 1.2.3 Global Antifungal Drugs for Skin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Antifungal Drugs for Skin Market Dynamics
  1. 2.1 Antifungal Drugs for Skin Industry Trends
  2. 2.2 Antifungal Drugs for Skin Industry Drivers
  3. 2.3 Antifungal Drugs for Skin Industry Opportunities and Challenges
  4. 2.4 Antifungal Drugs for Skin Industry Restraints
3 Antifungal Drugs for Skin Market by Company
  1. 3.1 Global Antifungal Drugs for Skin Company Revenue Ranking in 2025
  2. 3.2 Global Antifungal Drugs for Skin Revenue by Company (2021-2026)
  3. 3.3 Global Antifungal Drugs for Skin Sales Volume by Company (2021-2026)
  4. 3.4 Global Antifungal Drugs for Skin Average Price by Company (2021-2026)
  5. 3.5 Global Antifungal Drugs for Skin Company Ranking (2024-2026)
  6. 3.6 Global Antifungal Drugs for Skin Company Manufacturing Base and Headquarters
  7. 3.7 Global Antifungal Drugs for Skin Company Product Type and Application
  8. 3.8 Global Antifungal Drugs for Skin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Antifungal Drugs for Skin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Antifungal Drugs for Skin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Antifungal Drugs for Skin Market by Type
  1. 4.1 Antifungal Drugs for Skin Type Introduction
  2. 4.1.1 Amorolfine
  3. 4.1.2 Butenafine
  4. 4.1.3 Ciprofloxacin
  5. 4.1.4 Clotrimazole
  6. 4.1.5 Miconazole
  7. 4.1.6 Terbinafine
  8. 4.1.7 Ketoconazole
  9. 4.1.8 Econazole
  10. 4.1.9 Other
  11. 4.2 Global Antifungal Drugs for Skin Sales Volume by Type
  12. 4.2.1 Global Antifungal Drugs for Skin Sales Volume by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Antifungal Drugs for Skin Sales Volume by Type (2021-2032)
  14. 4.2.3 Global Antifungal Drugs for Skin Sales Volume Share by Type (2021-2032)
  15. 4.3 Global Antifungal Drugs for Skin Sales Value by Type
  16. 4.3.1 Global Antifungal Drugs for Skin Sales Value by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Antifungal Drugs for Skin Sales Value by Type (2021-2032)
  18. 4.3.3 Global Antifungal Drugs for Skin Sales Value Share by Type (2021-2032)
5 Antifungal Drugs for Skin Market by Application
  1. 5.1 Antifungal Drugs for Skin Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Antifungal Drugs for Skin Sales Volume by Application
  6. 5.2.1 Global Antifungal Drugs for Skin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antifungal Drugs for Skin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Antifungal Drugs for Skin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Antifungal Drugs for Skin Sales Value by Application
  10. 5.3.1 Global Antifungal Drugs for Skin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Antifungal Drugs for Skin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Antifungal Drugs for Skin Sales Value Share by Application (2021-2032)
6 Antifungal Drugs for Skin Regional Sales and Value Analysis
  1. 6.1 Global Antifungal Drugs for Skin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antifungal Drugs for Skin Sales by Region (2021-2032)
  3. 6.2.1 Global Antifungal Drugs for Skin Sales by Region: 2021-2026
  4. 6.2.2 Global Antifungal Drugs for Skin Sales by Region (2027-2032)
  5. 6.3 Global Antifungal Drugs for Skin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Antifungal Drugs for Skin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Antifungal Drugs for Skin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Antifungal Drugs for Skin Sales Value by Region (2027-2032)
  9. 6.5 Global Antifungal Drugs for Skin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Antifungal Drugs for Skin Sales Value (2021-2032)
  12. 6.6.2 North America Antifungal Drugs for Skin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Antifungal Drugs for Skin Sales Value (2021-2032)
  15. 6.7.2 Europe Antifungal Drugs for Skin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Antifungal Drugs for Skin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Antifungal Drugs for Skin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Antifungal Drugs for Skin Sales Value (2021-2032)
  21. 6.9.2 South America Antifungal Drugs for Skin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Antifungal Drugs for Skin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Antifungal Drugs for Skin Sales Value Share by Country, 2025 VS 2032
7 Antifungal Drugs for Skin Country-level Sales and Value Analysis
  1. 7.1 Global Antifungal Drugs for Skin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antifungal Drugs for Skin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Antifungal Drugs for Skin Sales by Country (2021-2032)
  4. 7.3.1 Global Antifungal Drugs for Skin Sales by Country (2021-2026)
  5. 7.3.2 Global Antifungal Drugs for Skin Sales by Country (2027-2032)
  6. 7.4 Global Antifungal Drugs for Skin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Antifungal Drugs for Skin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Antifungal Drugs for Skin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Antifungal Drugs for Skin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Antifungal Drugs for Skin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Antifungal Drugs for Skin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aden Healthcare
  2. 8.1.1 Aden Healthcare Company Information
  3. 8.1.2 Aden Healthcare Business Overview
  4. 8.1.3 Aden Healthcare Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Aden Healthcare Antifungal Drugs for Skin Product Portfolio
  6. 8.1.5 Aden Healthcare Recent Developments
  7. 8.2 AdvaCare Pharma
  8. 8.2.1 AdvaCare Pharma Company Information
  9. 8.2.2 AdvaCare Pharma Business Overview
  10. 8.2.3 AdvaCare Pharma Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AdvaCare Pharma Antifungal Drugs for Skin Product Portfolio
  12. 8.2.5 AdvaCare Pharma Recent Developments
  13. 8.3 Amar Healthcare
  14. 8.3.1 Amar Healthcare Company Information
  15. 8.3.2 Amar Healthcare Business Overview
  16. 8.3.3 Amar Healthcare Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Amar Healthcare Antifungal Drugs for Skin Product Portfolio
  18. 8.3.5 Amar Healthcare Recent Developments
  19. 8.4 AS lifesciences
  20. 8.4.1 AS lifesciences Company Information
  21. 8.4.2 AS lifesciences Business Overview
  22. 8.4.3 AS lifesciences Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AS lifesciences Antifungal Drugs for Skin Product Portfolio
  24. 8.4.5 AS lifesciences Recent Developments
  25. 8.5 Dr. Reddy's Laboratories
  26. 8.5.1 Dr. Reddy's Laboratories Company Information
  27. 8.5.2 Dr. Reddy's Laboratories Business Overview
  28. 8.5.3 Dr. Reddy's Laboratories Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Dr. Reddy's Laboratories Antifungal Drugs for Skin Product Portfolio
  30. 8.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Antifungal Drugs for Skin Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Shree Ganesh Remedies
  38. 8.7.1 Shree Ganesh Remedies Company Information
  39. 8.7.2 Shree Ganesh Remedies Business Overview
  40. 8.7.3 Shree Ganesh Remedies Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shree Ganesh Remedies Antifungal Drugs for Skin Product Portfolio
  42. 8.7.5 Shree Ganesh Remedies Recent Developments
  43. 8.8 Solisom Healthcare
  44. 8.8.1 Solisom Healthcare Company Information
  45. 8.8.2 Solisom Healthcare Business Overview
  46. 8.8.3 Solisom Healthcare Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Solisom Healthcare Antifungal Drugs for Skin Product Portfolio
  48. 8.8.5 Solisom Healthcare Recent Developments
  49. 8.9 Wellona Pharma
  50. 8.9.1 Wellona Pharma Company Information
  51. 8.9.2 Wellona Pharma Business Overview
  52. 8.9.3 Wellona Pharma Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Wellona Pharma Antifungal Drugs for Skin Product Portfolio
  54. 8.9.5 Wellona Pharma Recent Developments
  55. 8.10 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
  56. 8.10.1 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  60. 8.10.5 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Harbin Labton Pharmaceutical Co., Ltd.
  62. 8.11.1 Harbin Labton Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Harbin Labton Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  66. 8.11.5 Harbin Labton Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Harbin Pharmaceutical Group Bioengineering Co., Ltd.
  68. 8.12.1 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Company Information
  69. 8.12.2 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Business Overview
  70. 8.12.3 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  72. 8.12.5 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Recent Developments
  73. 8.13 Hubei Hengan Fulin Pharmaceutical Co., Ltd.
  74. 8.13.1 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  78. 8.13.5 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Jiangsu Chenpai Pharmaceutical Group Co., Ltd.
  80. 8.14.1 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Company Information
  81. 8.14.2 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Business Overview
  82. 8.14.3 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  84. 8.14.5 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Recent Developments
  85. 8.15 Livzon Group Livzon Pharmaceutical Factory
  86. 8.15.1 Livzon Group Livzon Pharmaceutical Factory Company Information
  87. 8.15.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
  88. 8.15.3 Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Product Portfolio
  90. 8.15.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
  91. 8.16 Lunan Beite Pharmaceutical Co., Ltd.
  92. 8.16.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Lunan Beite Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  96. 8.16.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Nanjing Chengong Pharmaceutical Co., Ltd.
  98. 8.17.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  102. 8.17.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Qilu Pharmaceutical Co., Ltd.
  104. 8.18.1 Qilu Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  108. 8.18.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  110. 8.19.1 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  114. 8.19.5 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  116. 8.20.1 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information
  117. 8.20.2 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview
  118. 8.20.3 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  120. 8.20.5 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Developments
  121. 8.21 Shandong Fangming Pharmaceutical Group Co., Ltd.
  122. 8.21.1 Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information
  123. 8.21.2 Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview
  124. 8.21.3 Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  126. 8.21.5 Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments
  127. 8.22 Shanghai Baolong Pharmaceutical Co., Ltd.
  128. 8.22.1 Shanghai Baolong Pharmaceutical Co., Ltd. Company Information
  129. 8.22.2 Shanghai Baolong Pharmaceutical Co., Ltd. Business Overview
  130. 8.22.3 Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  132. 8.22.5 Shanghai Baolong Pharmaceutical Co., Ltd. Recent Developments
  133. 8.23 Teyi Pharmaceutical Group Co., Ltd.
  134. 8.23.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
  135. 8.23.2 Teyi Pharmaceutical Group Co., Ltd. Business Overview
  136. 8.23.3 Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  138. 8.23.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments
  139. 8.24 Southwest Pharmaceutical Co., Ltd.
  140. 8.24.1 Southwest Pharmaceutical Co., Ltd. Company Information
  141. 8.24.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  142. 8.24.3 Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  144. 8.24.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  145. 8.25 Yunnan Longrun Pharmaceutical Co., Ltd.
  146. 8.25.1 Yunnan Longrun Pharmaceutical Co., Ltd. Company Information
  147. 8.25.2 Yunnan Longrun Pharmaceutical Co., Ltd. Business Overview
  148. 8.25.3 Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  150. 8.25.5 Yunnan Longrun Pharmaceutical Co., Ltd. Recent Developments
  151. 8.26 Zhejiang East Asia Pharmaceutical Co., Ltd.
  152. 8.26.1 Zhejiang East Asia Pharmaceutical Co., Ltd. Company Information
  153. 8.26.2 Zhejiang East Asia Pharmaceutical Co., Ltd. Business Overview
  154. 8.26.3 Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  156. 8.26.5 Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antifungal Drugs for Skin Value Chain Analysis
  2. 9.1.1 Antifungal Drugs for Skin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antifungal Drugs for Skin Sales Mode & Process
  6. 9.2 Antifungal Drugs for Skin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antifungal Drugs for Skin Distributors
  9. 9.2.3 Antifungal Drugs for Skin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst